MichaelWilliamDunneMD

PubMed

• Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.
  Judith Hsia, Alex C Spyropoulos, Gregory Piazza, Stephen Weng, Concetta Lipardi, Dunne, M. W., Michael W Dunne, Elliot S Barnathan, Marc P Bonaca> ;Thrombosis and Haemostasis. 2023 Dec 21
• 7 citations
  Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
  Steven I Aronin, Anita F Das, Karthik Akinapelli, Michael T Zelasky, Sailaja Puttagunta, Helen W Boucher, Dunne, M. W., Michael W Dunne> ;Clinical Infectious Diseases. 2023 Jan 6
• 7 citations
  Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
  Michael W Dunne, Steven I Aronin, Anita F Das, Karthik Akinapelli, Jeanne Breen, Michael T Zelasky, Sailaja Puttagunta> ;Clinical Infectious Diseases. 2023 Jan 6
• 2 citations
  Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 - 2020.
  Steven I Aronin, Kalvin C Yu, Janet A Watts, Vikas Gupta, Dunne, M. W., Michael W Dunne> ;Diagnostic Microbiology and Infectious Disease. 2022 Aug 1
• 7 citations
  Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020.
  Steven I Aronin, Vikas Gupta, Michael W Dunne, Janet A Watts, Kalvin C Yu> ;International Journal of Infectious Diseases. 2022 Jun 1
• 8 citations
  A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
  Steven I Aronin, Kalvin C Yu, Janet A Watts, Vikas Gupta, Dunne, M. W., Michael W Dunne> ;BMC Infectious Diseases. 2022 Feb 28
• 10 citations
  Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible.
  Sailaja Puttagunta, Steven I Aronin, Stephen Brossette, John Murray, Vikas Gupta, Dunne, M. W., Michael W Dunne> ;Microbiology Spectrum. 2022 Feb 23
• 2 citations
  Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials.
  Pedro L Gonzalez, Urania Rappo, Karthik Akinapelli, Jennifer S McGregor, Sailaja Puttagunta, Dunne, M. W., Michael W Dunne> ;Infectious Diseases and Therapy. 2022 Feb 1
• 4 citations
  Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analys...
  Pedro L Gonzalez, Urania Rappo, Veronica Mas Casullo, Karthik Akinapelli, Jennifer S McGregor, Jennifer C. Nelson, Michael Nowak, Sailaja Puttagunta, Dunne, M. W., Mic...> ;Infectious Diseases and Therapy. 2021 Jan 30
• 18 citations
  In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
  James A. Karlowsky, Heather J. Adam, Melanie R. Baxter, Andrew J Denisuik, Philippe Lagacé-Wiens, Andrew Walkty, Sailaja Puttagunta, George G. Zhanel, Dunne, M. W., Mi...> ;Antimicrobial Agents and Chemotherapy. 2019 Jan 1
• 28 citations
  Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.
  Daniel Gonzalez, John S. Bradley, Jeffrey L. Blumer, Ram Yogev, Kevin M. Watt, Laura P. James, Debra L. Palazzi, Varsha Bhatt-Mehta, Janice E. Sullivan, Li Zhang, Jenn...> ;The Pediatric Infectious Disease Journal. 2017 Jul 1
• 154 citations
  A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
  Michael W. Dunne, Sailaja Puttagunta, Philip Giordano, Dainis Krievins, Michael Zelasky, James Baldassarre> ;Clinical Infectious Diseases. 2016 Mar 1
• 31 citations
  Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis
  Yoav Barnea, Anat Lerner, Asaf Aizic, Shiri Navon-Venezia, Eleanor Rachi, Sailaja Puttagunta, Yehuda Carmeli, Dunne, M. W., Michael W. Dunne> ;The Journal of Antimicrobial Chemotherapy. 2016 Feb 1
• 52 citations
  Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies.
  George H. Talbot, Helen W. Boucher, Mark H. Wilcox, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Drug Safety. 2016 Feb 1
• 37 citations
  In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program
  Sandra P. McCurdy, Ronald N. Jones, Rodrigo E. Mendes, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Antimicrobial Agents and Chemotherapy. 2015 Aug 1
• 31 citations
  Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
  Ronald N. Jones, David J. Farrell, Robert K. Flamm, Helio S. Sader, Rodrigo E. Mendes, Dunne, M. W., Michael W. Dunne> ;Diagnostic Microbiology and Infectious Disease. 2015 May 1
• 18 citations
  Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies.
  Dan Sahm, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Annals of Clinical Microbiology and Antimicrobials. 2015 Apr 2
• 24 citations
  A thorough QT study with dalbavancin: A novel lipoglycopeptide antibiotic for the treatment of acute bacterial skin and skin-structure infections
  Meijian Zhou, Borje Darpo, Dunne, M. W., Michael W. Dunne> ;International Journal of Antimicrobial Agents. 2015 Apr 1
• 42 citations
  Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised c...
  Issaka Sagara, Abraham Oduro, Modest Mulenga, Yémou Dieng, Bernhards Ogutu, Alfred B. Tiono, Peter Mugyenyi, Ali Sié, Monique Wasunna, Kevin C. Kain, Abdoulaye Djimde,...> ;Malaria Journal. 2014 Nov 25
• 578 citations
  Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
  Dunne, M. W., Roy M. Gulick, Jacob Lalezari, James Goodrich, Nathan Clumeck, Edwin DeJesus, Andrzej Horban, Jeffrey P. Nadler, Bonaventura Clotet, Anders Karlsson, Mic...> ;The New England Journal of Medicine. 2008 Oct 2
• 276 citations
  Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
  Dunne, M. W., Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin, Irina Konourina, Andy I. M. Hoepelman, Harry Lampiris, Bernard Hirschel, Pablo Tebas, François Raffi, Be...> ;The New England Journal of Medicine. 2008 Oct 2
• 111 citations
  In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin
  Amar Bir Singh Sidhu, Qingan Sun, Louis J. Nkrumah, James C. Sacchettini, David A. Fidock, Dunne, M. W., Michael W. Dunne> ;The Journal of Biological Chemistry. 2007 Jan 26
• 30 citations
  Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease
  David Aguilar, Marian R. Fisher, Christopher M. O'Connor, Joseph B. Muhlestein, Louis Yao, Sandeep Gupta, Rebecca J. Benner, Thomas D. Cook, Dearborn Edwards, Marc A. ...> ;American Heart Journal. 2006 Aug 1
• 31 citations
  A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
  Neeru Singh, M. M. Shukla, Neena Valecha, P C Bhattacharyya, Kanta Patel, Manoj Mohapatra, Jitendra D Lakhani, C. Usha Devi, Tridibes Adak, Vas Dev, Rajpal S. Yadav, C...> ;The American Journal of Tropical Medicine and Hygiene. 2005 Dec 1
• 75 citations
  A Multicenter Study of Azithromycin, Alone and in Combination with Chloroquine, for the Treatment of Acute Uncomplicated Plasmodium falciparum Malaria in India
  Neeru Singh, M. M. Shukla, Neena Valecha, P C Bhattacharyya, Vas Dev, Kanta Patel, Manoj K. Mohapatra, Jitendra D Lakhani, Rebecca J. Benner, Chitra Lele, Kiran Patki,...> ;The Journal of Infectious Diseases. 2005 May 15
• Join now to see all